$ALMU

Aeluma, Inc.

No enriched coverage for $ALMU in the last 7 days.

—
$2.4M
Klamkin Jonathan
100%
See all $ALMU insider activity →

Aeluma (ALMU) Q4 2026 Earnings Call Transcript

Aeluma (ALMU) reported Q4 2026 revenue of $582,000 and a GAAP net loss of $4 million, or $0.22 per share. Full-year revenue was $4.5 million, down from $4.7 million in 2025. The company is shifting focus to the AI datacom market, investing in manufacturing and hiring, with $56 million in cash reserves. It expects $2.3 million in government revenue for 2027 and is pursuing additional contracts and partnerships.

ALMU sentiment & insider activity

Recent ALMU coverage spans insider activity, earnings and market movers.

In the last 30 days, ALMU insiders filed 2 SEC Form 4 transactions — no purchases and 2 sales ($2.4M). The most active reporter was Klamkin Jonathan, Chief Executive Officer, with 2 filings. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.

What's driving ALMU

  • The insider sale may signal reduced confidence and could pressure the stock lower.

    SEC EDGAR · Oct 14, 2026

  • Significant insider sell may signal lack of confidence, potentially pressuring the stock short-term.

    SEC EDGAR · Sep 23, 2026

  • Earnings miss and increased loss suggest near‑term pressure, but $30M CHIPS award and new government contracts could support longer‑term upside.

    aol.com · Sep 17, 2026

  • Earnings miss and cash raise suggest near‑term dilution pressure but improved cash balance for growth.

    SEC EDGAR 8-K · Sep 16, 2026

  • Aeluma stock rose 7.0% in pre-market trading after announcing a partnership with Sumitomo Chemical Advanced Technologies to develop and manufacture photonics wafers for AI datacom. The company is set to report Q4 and full-year 2026 earnings on September 16. The sole analyst's price target of $30.50 suggests significant upside from current levels.

    investing.com · Sep 15, 2026

AlphAI scores every news story that mentions ALMU with an AI model for sentiment and relevance, and aggregates insider trades from Aeluma, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $ALMU

Score
$ALMUMed

Aeluma (ALMU) Q4 2026 Earnings Call Transcript

Aeluma (ALMU) reported Q4 2026 revenue of $582,000 and a GAAP net loss of $4 million, or $0.22 per share. Full-year revenue was $4.5 million, down from $4.7 million in 2025. The company is shifting focus to the AI datacom market, investing in manufacturing and hiring, with $56 million in cash reserves. It expects $2.3 million in government revenue for 2027 and is pursuing additional contracts and partnerships.

High

Why is Aeluma stock surging today?

Aeluma stock rose 7.0% in pre-market trading after announcing a partnership with Sumitomo Chemical Advanced Technologies to develop and manufacture photonics wafers for AI datacom. The company is set to report Q4 and full-year 2026 earnings on September 16. The sole analyst's price target of $30.50 suggests significant upside from current levels.

The Speed of Light: 5 Stocks Powering AI’s Optical Future

MarketBeat highlights NVIDIA’s broader photonics investment and says the global photonics market is about $1.25T, growing mid-single digits through the next decade, with silicon photonics rising ~30% annually. It profiles Aeluma (NASDAQ: ALMU), citing quantum-dot lasers and a manufacturing method that grows optical-quality substrate on silicon. The article notes Aeluma is pre-revenue, seeks data-center/defense partnerships for design wins and prototype certifications, and targets production and

$ALMUMedAI 8/10

Aeluma Sees Accelerated Timeline for Quantum Commercialization

Aeluma (NASDAQ: ALMU) said the U.S. Department of Commerce announced proposed CHIPS Act incentives of more than $2 billion for nine companies to accelerate quantum computing, shifting from R&D to manufacturing. Aeluma supported one company that signed a letter of intent, with involvement contingent on a subcontract. Aeluma cited its scalable wafer platform and recent U.S. contracts for quantum materials and lasers.

Comparing Cerebras Systems (NASDAQ:CBRS) & Aeluma (NASDAQ:ALMU)

MarketBeat.com compares Cerebras Systems (CBRS) and Aeluma (ALMU). It reports Aeluma has a consensus price target of $25.33 (about 4% upside) and a stronger consensus rating. The article also states Cerebras has higher revenue and earnings, while profitability metrics are compared via net margin and returns on equity/assets.

Related tickers